Burosumab
ATC M05BX05 · 9 markets · 38 records
AU 10 records · 7 strengths
- 10 mginjectionCRYSVITA burosumab 10 mg/0.33 mL solution for injection in a 1 mL pre-filled syringeCRYSVITA burosumab 10 mg/mL solution for injection in a 5 mL vial
- 30 mginjectionCRYSVITA burosumab 10 mg/0.33 mL solution for injection in a 1 mL pre-filled syringeCRYSVITA burosumab 10 mg/mL solution for injection in a 5 mL vial
- 20 mginjectionCRYSVITA burosumab 10 mg/0.33 mL solution for injection in a 1 mL pre-filled syringeCRYSVITA burosumab 10 mg/mL solution for injection in a 5 mL vial
- 30 mg/1 mLinjectionCRYSVITA
- 20 mg/1 mLinjectionCRYSVITA
- 10 mg/1 mLinjectionCRYSVITA
Records without a stated strength · 1 CRYSVITA
GB 6 records · 5 strengths
- 30 mg/1 mLinjectionCrysvita 10mg/0.33ml solution for injection pre-filled syringesCrysvita 10mg/1ml solution for injection vials
- 20 mg/1 mLinjectionCrysvita 10mg/1ml solution for injection vials
- 10 mg/1 mLinjectionCrysvita 10mg/1ml solution for injection vials
- 20 mg/0.67 mLinjectionCrysvita 10mg/0.33ml solution for injection pre-filled syringes
- 10 mg/0.33 mLinjectionCrysvita 10mg/0.33ml solution for injection pre-filled syringes
ES 6 records · 5 strengths
- 10 mginjectionCRYSVITACRYSVITA PRECARGADA
- 30 mginjectionCRYSVITA PRECARGADA
- 20 mginjectionCRYSVITA PRECARGADA
- 30 mg/1 mLinjectionCRYSVITA
- 20 mg/1 mLinjectionCRYSVITA
US 3 records · 3 strengths
CA 3 records · 3 strengths
SG 3 records · 3 strengths
- 30 mg/mLinjectionCRYSVITA® SOLUTION FOR INJECTION 20 MG/ML
- 20 mg/mLinjectionCRYSVITA® SOLUTION FOR INJECTION 20 MG/ML
- 10 mg/mLinjectionCRYSVITA® SOLUTION FOR INJECTION 20 MG/ML
TW 3 records · 3 strengths
- 10 mginjectionCRYSVITA 10mg solution for磷平 10毫克注射液
- 30 mginjectionCRYSVITA 10mg solution for磷平 30毫克注射液
- 20 mginjectionCRYSVITA 10mg solution for磷平 20毫克注射液
HK 3 records · 1 strengths
Records without a stated strength · 1 CRYSVITA 10mg solution for injection
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 CRYSVITA
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
8 more strength/form rows are recorded only in GB · CA · SG and are not shown in this table. Hay 8 filas de concentración/forma registradas solo en GB · CA · SG que no se muestran en esta tabla. 另有 8 个规格/剂型仅在 GB · CA · SG 有记录(未在本表显示)。 另有 8 個規格/劑型僅在 GB · CA · SG 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.